51 results
PRE 14A
LRMR
Larimar Therapeutics Inc
12 Apr 24
Preliminary proxy
6:06am
Governance Committee
CORPORATE GOVERNANCE HIGHLIGHTS
The following table summarizes our current Board structure and key elements of our corporate … governance framework:
GOVERNANCE ITEMS
Size of Board (set by the Board)
Number of Independent Directors
Independent Chairperson of the Board
Yes
Board
8-K
LRMR
Larimar Therapeutics Inc
3 Oct 23
Departure of Directors or Certain Officers
4:31pm
of the Nominating and Corporate Governance Committee, appointed Jeffrey W. Sherman, MD, FACP to serve as a Class I director, with an initial term expiring … at the Company’s 2024 Annual Meeting of Stockholders, and a member of the Nominating and Corporate Governance Committee.
Dr. Sherman, 68, has served
8-K/A
EX-99.2
exhel0sv
26 Jun 20
Other Events
5:08pm
8-K
EX-14.1
s9u9slp6
2 Jun 20
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
7:49am
8-K
zim7tiyfd
2 Jun 20
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
7:49am
DEFM14A
czdhkjcau0m
29 Apr 20
Proxy related to merger
3:20pm
PRER14A
omeegj1hp6puqwl00v
10 Apr 20
Preliminary revised proxy
4:38pm
PREM14A
y6qgvlwj
6 Mar 20
Preliminary proxy related to merger
5:32pm